APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tolvaptan Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tolvaptan Tablets Industry Growth and Trends Forecast to 2032

Report ID 174041810120 December 202592 pages

Choose your research edition.

Industry ResearchTolvaptan Tablets Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Tolvaptan Tablets Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Tolvaptan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tolvaptan Tablets Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Tolvaptan Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Tolvaptan Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tolvaptan Tablets include CHIA TAI TIANQING PHARMACEUTICAL GROUP, Jiangsu Hengrui Pharmaceuticals, Chengdu Brilliant Pharmaceutical, Chengdu Baiyu Pharmaceutical, Otsuka Pharmaceutical and Healing Pharma India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tolvaptan Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tolvaptan Tablets market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tolvaptan Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tolvaptan Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tolvaptan Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tolvaptan Tablets Market by Company

CHIA TAI TIANQING PHARMACEUTICAL GROUP

Jiangsu Hengrui Pharmaceuticals

Chengdu Brilliant Pharmaceutical

Chengdu Baiyu Pharmaceutical

Otsuka Pharmaceutical

Healing Pharma India

Tolvaptan Tablets Segment by Type

15mg

30mg

Tolvaptan Tablets Segment by Application

Clinic

Hospital

Pharmacy

Tolvaptan Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tolvaptan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tolvaptan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tolvaptan Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tolvaptan Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tolvaptan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 15mg Table 2. Major Company of 30mg Table 3. Global Tolvaptan Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tolvaptan Tablets Sales by Type (2021-2026) & (units) Table 5. Global Tolvaptan Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tolvaptan Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tolvaptan Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Tolvaptan Tablets Price by Type (2021-2026) & (US$/unit) Table 9. Global Tolvaptan Tablets Sales by Type (2027-2032) & (units) Table 10. Global Tolvaptan Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tolvaptan Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tolvaptan Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Tolvaptan Tablets Price by Type (2027-2032) & (US$/unit) Table 14. North America Tolvaptan Tablets Sales by Type (2021-2026) & (units) Table 15. North America Tolvaptan Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tolvaptan Tablets Sales by Type (2021-2026) & (units) Table 17. Europe Tolvaptan Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tolvaptan Tablets Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Tolvaptan Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tolvaptan Tablets Sales by Type (2021-2026) & (units) Table 21. Latin America Tolvaptan Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tolvaptan Tablets Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Tolvaptan Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Tolvaptan Tablets Industry Trends Table 25. Tolvaptan Tablets Industry Drivers Table 26. Tolvaptan Tablets Industry Opportunities and Challenges Table 27. Tolvaptan Tablets Industry Restraints Table 28. Global Tolvaptan Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tolvaptan Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Tolvaptan Tablets Sales by Company (2021-2026) & (units) Table 31. Global Tolvaptan Tablets Sales Share by Company (2021-2026) Table 32. Global Tolvaptan Tablets Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Tolvaptan Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tolvaptan Tablets Major Company Production Sites and Headquarters Table 35. Global Tolvaptan Tablets Company, Product Type & Application Table 36. Global Tolvaptan Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tolvaptan Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tolvaptan Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tolvaptan Tablets Sales by Region (2021-2026) & (units) Table 41. Global Tolvaptan Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tolvaptan Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tolvaptan Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Tolvaptan Tablets Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Tolvaptan Tablets Sales by Region (2027-2032) & (units) Table 46. Global Tolvaptan Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tolvaptan Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tolvaptan Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Tolvaptan Tablets Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Tolvaptan Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tolvaptan Tablets Sales by Application (2021-2026) & (units) Table 52. Global Tolvaptan Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tolvaptan Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tolvaptan Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Tolvaptan Tablets Price by Application (2021-2026) & (US$/unit) Table 56. Global Tolvaptan Tablets Sales by Application (2027-2032) & (units) Table 57. Global Tolvaptan Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tolvaptan Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tolvaptan Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Tolvaptan Tablets Price by Application (2027-2032) & (US$/unit) Table 61. North America Tolvaptan Tablets Sales by Application (2021-2026) & (units) Table 62. North America Tolvaptan Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tolvaptan Tablets Sales by Application (2021-2026) & (units) Table 64. Europe Tolvaptan Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tolvaptan Tablets Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Tolvaptan Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tolvaptan Tablets Sales by Application (2021-2026) & (units) Table 68. Latin America Tolvaptan Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tolvaptan Tablets Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Tolvaptan Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information Table 72. CHIA TAI TIANQING PHARMACEUTICAL GROUP Business Overview Table 73. CHIA TAI TIANQING PHARMACEUTICAL GROUP Tolvaptan Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. CHIA TAI TIANQING PHARMACEUTICAL GROUP Tolvaptan Tablets Product Portfolio Table 75. CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Development Table 76. Jiangsu Hengrui Pharmaceuticals Company Information Table 77. Jiangsu Hengrui Pharmaceuticals Business Overview Table 78. Jiangsu Hengrui Pharmaceuticals Tolvaptan Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Jiangsu Hengrui Pharmaceuticals Tolvaptan Tablets Product Portfolio Table 80. Jiangsu Hengrui Pharmaceuticals Recent Development Table 81. Chengdu Brilliant Pharmaceutical Company Information Table 82. Chengdu Brilliant Pharmaceutical Business Overview Table 83. Chengdu Brilliant Pharmaceutical Tolvaptan Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Chengdu Brilliant Pharmaceutical Tolvaptan Tablets Product Portfolio Table 85. Chengdu Brilliant Pharmaceutical Recent Development Table 86. Chengdu Baiyu Pharmaceutical Company Information Table 87. Chengdu Baiyu Pharmaceutical Business Overview Table 88. Chengdu Baiyu Pharmaceutical Tolvaptan Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Chengdu Baiyu Pharmaceutical Tolvaptan Tablets Product Portfolio Table 90. Chengdu Baiyu Pharmaceutical Recent Development Table 91. Otsuka Pharmaceutical Company Information Table 92. Otsuka Pharmaceutical Business Overview Table 93. Otsuka Pharmaceutical Tolvaptan Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Otsuka Pharmaceutical Tolvaptan Tablets Product Portfolio Table 95. Otsuka Pharmaceutical Recent Development Table 96. Healing Pharma India Company Information Table 97. Healing Pharma India Business Overview Table 98. Healing Pharma India Tolvaptan Tablets Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Healing Pharma India Tolvaptan Tablets Product Portfolio Table 100. Healing Pharma India Recent Development Table 101. North America Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 102. North America Tolvaptan Tablets Sales by Country (2021-2026) & (units) Table 103. North America Tolvaptan Tablets Sales Market Share by Country (2021-2026) Table 104. North America Tolvaptan Tablets Sales Forecast by Country (2027-2032) & (units) Table 105. North America Tolvaptan Tablets Sales Market Share Forecast by Country (2027-2032) Table 106. North America Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Tolvaptan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Tolvaptan Tablets Market Share by Country (2021-2026) Table 109. North America Tolvaptan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Tolvaptan Tablets Market Share Forecast by Country (2027-2032) Table 111. Europe Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 112. Europe Tolvaptan Tablets Sales by Country (2021-2026) & (units) Table 113. Europe Tolvaptan Tablets Sales Market Share by Country (2021-2026) Table 114. Europe Tolvaptan Tablets Sales Forecast by Country (2027-2032) & (units) Table 115. Europe Tolvaptan Tablets Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Tolvaptan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Tolvaptan Tablets Market Share by Country (2021-2026) Table 119. Europe Tolvaptan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Tolvaptan Tablets Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Tolvaptan Tablets Sales by Country (2021-2026) & (units) Table 123. Asia-Pacific Tolvaptan Tablets Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Tolvaptan Tablets Sales Forecast by Country (2027-2032) & (units) Table 125. Asia-Pacific Tolvaptan Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Tolvaptan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Tolvaptan Tablets Market Share by Country (2021-2026) Table 129. Asia-Pacific Tolvaptan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Tolvaptan Tablets Market Share Forecast by Country (2027-2032) Table 131. Latin America Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 132. Latin America Tolvaptan Tablets Sales by Country (2021-2026) & (units) Table 133. Latin America Tolvaptan Tablets Sales Market Share by Country (2021-2026) Table 134. Latin America Tolvaptan Tablets Sales Forecast by Country (2027-2032) & (units) Table 135. Latin America Tolvaptan Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Tolvaptan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Tolvaptan Tablets Market Share by Country (2021-2026) Table 139. Latin America Tolvaptan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Tolvaptan Tablets Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Tolvaptan Tablets Sales by Country (2021-2026) & (units) Table 143. Middle East and Africa Tolvaptan Tablets Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Tolvaptan Tablets Sales Forecast by Country (2027-2032) & (units) Table 145. Middle East and Africa Tolvaptan Tablets Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Tolvaptan Tablets Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Tolvaptan Tablets Market Share by Country (2021-2026) Table 149. Middle East and Africa Tolvaptan Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Tolvaptan Tablets Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Tolvaptan Tablets Distributors List Table 154. Tolvaptan Tablets Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Tolvaptan Tablets Image Figure 2. Global Tolvaptan Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tolvaptan Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Tolvaptan Tablets Sales (2021-2032) & (units) Figure 5. 15mg Image Figure 6. Global 15mg Sales YoY Growth (2021-2032) & (units) Figure 7. 30mg Image Figure 8. Global 30mg Sales YoY Growth (2021-2032) & (units) Figure 9. Global Tolvaptan Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tolvaptan Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Tolvaptan Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Tolvaptan Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Tolvaptan Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tolvaptan Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tolvaptan Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tolvaptan Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tolvaptan Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tolvaptan Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tolvaptan Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tolvaptan Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tolvaptan Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (units) Figure 29. Global Tolvaptan Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tolvaptan Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Tolvaptan Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Tolvaptan Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Tolvaptan Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tolvaptan Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tolvaptan Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tolvaptan Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tolvaptan Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tolvaptan Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tolvaptan Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tolvaptan Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Tolvaptan Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 42. North America Tolvaptan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tolvaptan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tolvaptan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tolvaptan Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 46. Europe Tolvaptan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tolvaptan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tolvaptan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tolvaptan Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 50. Asia-Pacific Tolvaptan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tolvaptan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tolvaptan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tolvaptan Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 54. Latin America Tolvaptan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tolvaptan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tolvaptan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tolvaptan Tablets Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 58. Middle East and Africa Tolvaptan Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tolvaptan Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tolvaptan Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tolvaptan Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tolvaptan Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg
  • 30mg
Applications
  • Clinic
  • Hospital
  • Pharmacy
Companies covered
  • CHIA TAI TIANQING PHARMACEUTICAL GROUP
  • Jiangsu Hengrui Pharmaceuticals
  • Chengdu Brilliant Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Otsuka Pharmaceutical
  • Healing Pharma India

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tolvaptan Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tolvaptan Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tolvaptan Tablets Market by Type
  6. 1.3.1 15mg
  7. 1.3.2 30mg
  8. 1.4 Global Tolvaptan Tablets Market Size by Type
  9. 1.4.1 Global Tolvaptan Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tolvaptan Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tolvaptan Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tolvaptan Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tolvaptan Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tolvaptan Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tolvaptan Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tolvaptan Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tolvaptan Tablets Industry Trends
  2. 2.2 Tolvaptan Tablets Industry Drivers
  3. 2.3 Tolvaptan Tablets Industry Opportunities and Challenges
  4. 2.4 Tolvaptan Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tolvaptan Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Tolvaptan Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Tolvaptan Tablets Price (2021-2026)
  4. 3.4 Global Tolvaptan Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tolvaptan Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Tolvaptan Tablets Company, Product Type & Application
  7. 3.7 Global Tolvaptan Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tolvaptan Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tolvaptan Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tolvaptan Tablets Tier 1, Tier 2, and Tier 3
4 Tolvaptan Tablets Regional Status and Outlook
  1. 4.1 Global Tolvaptan Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tolvaptan Tablets Historic Market Size by Region
  3. 4.2.1 Global Tolvaptan Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tolvaptan Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tolvaptan Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tolvaptan Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Tolvaptan Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tolvaptan Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tolvaptan Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tolvaptan Tablets by Application
  1. 5.1 Tolvaptan Tablets Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.2 Global Tolvaptan Tablets Market Size by Application
  6. 5.2.1 Global Tolvaptan Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tolvaptan Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tolvaptan Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tolvaptan Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tolvaptan Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tolvaptan Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tolvaptan Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tolvaptan Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP
  2. 6.1.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information
  3. 6.1.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP Business Overview
  4. 6.1.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP Tolvaptan Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP Tolvaptan Tablets Product Portfolio
  6. 6.1.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Developments
  7. 6.2 Jiangsu Hengrui Pharmaceuticals
  8. 6.2.1 Jiangsu Hengrui Pharmaceuticals Company Information
  9. 6.2.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  10. 6.2.3 Jiangsu Hengrui Pharmaceuticals Tolvaptan Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Hengrui Pharmaceuticals Tolvaptan Tablets Product Portfolio
  12. 6.2.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  13. 6.3 Chengdu Brilliant Pharmaceutical
  14. 6.3.1 Chengdu Brilliant Pharmaceutical Company Information
  15. 6.3.2 Chengdu Brilliant Pharmaceutical Business Overview
  16. 6.3.3 Chengdu Brilliant Pharmaceutical Tolvaptan Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengdu Brilliant Pharmaceutical Tolvaptan Tablets Product Portfolio
  18. 6.3.5 Chengdu Brilliant Pharmaceutical Recent Developments
  19. 6.4 Chengdu Baiyu Pharmaceutical
  20. 6.4.1 Chengdu Baiyu Pharmaceutical Company Information
  21. 6.4.2 Chengdu Baiyu Pharmaceutical Business Overview
  22. 6.4.3 Chengdu Baiyu Pharmaceutical Tolvaptan Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chengdu Baiyu Pharmaceutical Tolvaptan Tablets Product Portfolio
  24. 6.4.5 Chengdu Baiyu Pharmaceutical Recent Developments
  25. 6.5 Otsuka Pharmaceutical
  26. 6.5.1 Otsuka Pharmaceutical Company Information
  27. 6.5.2 Otsuka Pharmaceutical Business Overview
  28. 6.5.3 Otsuka Pharmaceutical Tolvaptan Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Otsuka Pharmaceutical Tolvaptan Tablets Product Portfolio
  30. 6.5.5 Otsuka Pharmaceutical Recent Developments
  31. 6.6 Healing Pharma India
  32. 6.6.1 Healing Pharma India Company Information
  33. 6.6.2 Healing Pharma India Business Overview
  34. 6.6.3 Healing Pharma India Tolvaptan Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Healing Pharma India Tolvaptan Tablets Product Portfolio
  36. 6.6.5 Healing Pharma India Recent Developments
7 North America by Country
  1. 7.1 North America Tolvaptan Tablets Sales by Country
  2. 7.1.1 North America Tolvaptan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tolvaptan Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Tolvaptan Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tolvaptan Tablets Market Size by Country
  6. 7.2.1 North America Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tolvaptan Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Tolvaptan Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tolvaptan Tablets Sales by Country
  2. 8.1.1 Europe Tolvaptan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tolvaptan Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Tolvaptan Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tolvaptan Tablets Market Size by Country
  6. 8.2.1 Europe Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tolvaptan Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tolvaptan Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tolvaptan Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Tolvaptan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tolvaptan Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tolvaptan Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tolvaptan Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tolvaptan Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tolvaptan Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tolvaptan Tablets Sales by Country
  2. 10.1.1 South America Tolvaptan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tolvaptan Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Tolvaptan Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tolvaptan Tablets Market Size by Country
  6. 10.2.1 South America Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tolvaptan Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Tolvaptan Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tolvaptan Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Tolvaptan Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tolvaptan Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tolvaptan Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tolvaptan Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Tolvaptan Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tolvaptan Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tolvaptan Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tolvaptan Tablets Value Chain Analysis
  2. 12.1.1 Tolvaptan Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tolvaptan Tablets Production Mode & Process
  7. 12.2 Tolvaptan Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tolvaptan Tablets Distributors
  10. 12.2.3 Tolvaptan Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst